Columnnist

Bill Berkrot

Correspondent at Reuters with focus on biopharma and healthcare

Correspondent at Reuters with focus on biopharma and healthcare.

Bill Berkrot
6 Oct 2016

Profiting from Zika

The prospect of a blockbuster vaccine against a mosquito-borne virus has accelerated the pace of development and attracted the interest of big drugmakers.

6 Oct 2016
Profiting from Zika